Default company panoramic image

Pacific Nanoscience

The Nanomonitor measures biomarkers in patient blood faster, less expensive, and 10,000 times more sensitive than the current standard.

  • Stage Product In Development
  • Industry Nanotechnology
  • Location Portland, OR, USA
  • Currency USD
  • Founded October 2011
  • Employees 3

Company Summary

Pacific Nanoscience, Inc. (PacNano) is advancing a handheld point of care (POC) diagnostic product for the rapid, ultrasensitive detection of key biomarkers. The company is currently focused on troponin, which is the preferred biomarker used to diagnose heart attack. The Nanomonitor can measure troponin 13,000 times more sensitive than the current standard. Customers include physicians, hospitals, and patients.


  • Default avatar
    Julie Wrazel
    VP Strategic Alliances

    After a 29 year history with HP, Dr. Wrazel has gained expertise in micro-fluidic design with a critical understanding of high volume manufacturing and supply chain management. Dr. Wrazel has held multiple executive positions within HP, including Strategic Alliance Manager for key partnerships within the Imaging and Printing Group. She holds a Ph.D. in Chemistry from the University of Wisconsin and an MS in the Management of Innovation.

  • Default avatar
    Shalini Prasad
    CTO & Co-Founder

    Dr. Prasad is a nanotechnology research engineer originally from Portland State University, now located at University of Texas, Dallas. Pacific Nanoscience is a culmination from the last eight years of research from both OHSU and PSU, and is focused on the development and commercialization of applications surrounding the Nanomonitor. Dr. Prasad is the recipient of a number of awards in the area of nanobiotechnology.

  • Default avatar
    Thomas Barrett
    President & Co-Founder & CMO

    Dr. Barrett co-founded the Oregon Nanomedicine Interdisciplinary Research Group (ONIRG) in 2004. ONIRG is a group of researchers from nanotechnology, genomics, proteomics, biochemistry, biophysics, and clinical medicine. Dr. Barrett has served as the lead translational researcher for this group. Dr. Barrett transitioned ONIRG into PacNano, Co-Founding the company with Dr. Prasad.


  • Default avatar
    Michael Phillips, Davis Wright Tremaine